Intuitive Surgical (ISRG) Stock Forecast & Price Target

$521.15

+47.42 (+10.01%)

(As of 10/18/2024 08:52 PM ET)

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
1

Hold
4

Buy
14

Based on 19 Wall Street analysts who have issued ratings for Intuitive Surgical in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 1 has given a sell rating, 4 have given a hold rating, and 14 have given a buy rating for ISRG.

Consensus Price Target

$513.74
-1.42% Downside

According to the 19 analysts' twelve-month price targets for Intuitive Surgical, the average price target is $513.74. The highest price target for ISRG is $604.00, while the lowest price target for ISRG is $318.00. The average price target represents a forecasted downside of -1.42% from the current price of $521.15.

ISRG Analyst Ratings Over Time

Type	Current Forecast 10/22/23 to 10/21/24	1 Month Ago 9/22/23 to 9/21/24	3 Months Ago 7/24/23 to 7/23/24	1 Year Ago 10/22/22 to 10/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	14 Buy rating(s)	15 Buy rating(s)	14 Buy rating(s)	16 Buy rating(s)
Hold	4 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$513.74	$446.45	$438.74	$343.70
Forecasted Upside	-1.42% Downside	-8.18% Downside	-3.59% Downside	28.77% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Have you heard of Donald Trump’s Project Crypto? (Ad)

Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”

Learn More Here

ISRG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ISRG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Intuitive Surgical Stock vs. The Competition

Type	Intuitive Surgical	Medical Companies	S&P 500
Consensus Rating Score	2.68	2.79	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	-1.42% Downside	13,587.63% Upside	6.19% Upside
News Sentiment Rating	Positive News See Recent ISRG News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/18/2024	The Goldman Sachs Group 2 of 5 stars	David Roman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$604.00	+15.73%
10/18/2024	Oppenheimer 3 of 5 stars		Reiterated Rating	Market Perform ➝ Market Perform
10/18/2024	Evercore ISI 2 of 5 stars		Reiterated Rating	Cautious ➝ Cautious
10/18/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$535.00	+2.51%
10/18/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$466.00 ➝ $549.00	+7.06%
10/18/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rick Wise Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$475.00 ➝ $525.00	+2.38%
Have you heard of Donald Trump’s Project Crypto? (Ad) Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.” Learn More Here
10/18/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$495.00 ➝ $538.00	+4.92%
10/18/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shagun Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$525.00 ➝ $555.00	+8.40%
10/17/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$440.00 ➝ $500.00	+5.30%
10/17/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$489.00 ➝ $502.00	+5.72%
10/17/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$503.00 ➝ $565.00	+18.98%
10/14/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$500.00 ➝ $540.00	+11.06%
10/14/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Newitter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$520.00 ➝ $570.00	+17.78%
10/11/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$495.00 ➝ $575.00	+18.52%
8/22/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$512.00 ➝ $560.00	+14.31%
8/2/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Ridley-Day Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$380.00 ➝ $510.00	+13.10%
7/18/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$430.00 ➝ $490.00	+17.49%
7/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$375.00 ➝ $460.00	+5.42%
4/19/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$365.00 ➝ $375.00	+0.64%
11/17/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$318.00	+4.62%
10/19/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$385.00 ➝ $314.00	+14.82%
5/31/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$350.00 ➝ $365.00	+18.87%
4/19/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold	$245.00 ➝ $290.00	-4.27%
4/19/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$300.00 ➝ $315.00	+16.98%
3/23/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Vazquez Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
12/22/2022	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$265.00 ➝ $320.00	+20.23%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:04 AM ET.

Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 14, 2024. Please send any questions or comments about these Intuitive Surgical pros and cons to contact@marketbeat.com.

Intuitive Surgical
Bull Case

Here are some ways that investors could benefit from investing in Intuitive Surgical, Inc.:

Intuitive Surgical, Inc. has a strong market position in the field of minimally invasive care, providing a competitive edge in the healthcare industry.
The company's stock price has shown consistent growth, reaching $480.79 on the trading day of October 14, 2024, indicating positive investor sentiment.
Analysts have given Intuitive Surgical, Inc. a "Moderate Buy" rating with an average price target of $454.35, suggesting further potential for stock appreciation.
Recent insider transactions, including sales by company executives, may indicate confidence in the company's future performance and growth prospects.
Intuitive Surgical, Inc. continues to innovate and develop new products to enhance healthcare providers' capabilities, potentially driving future revenue growth.

Intuitive Surgical
Bear Case

Investors should be bearish about investing in Intuitive Surgical, Inc. for these reasons:

Despite positive analyst ratings, there is always inherent risk in investing in the stock market, and past performance is not indicative of future results.
The company's stock has a high price-to-earnings ratio of 86.93, which may indicate an overvaluation compared to industry peers.
Intuitive Surgical, Inc. operates in a highly competitive market, facing potential challenges from new entrants or technological disruptions.
Market volatility and macroeconomic factors can impact the stock price of Intuitive Surgical, Inc., leading to fluctuations in investor returns.
Regulatory changes or legal issues in the healthcare sector could affect the company's operations and financial performance, posing risks to investors.

ISRG Forecast - Frequently Asked Questions

: According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Intuitive Surgical is $513.74, with a high forecast of $604.00 and a low forecast of $318.00.
: 19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last twelve months. There is currently 1 sell rating, 4 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ISRG shares.
: According to analysts, Intuitive Surgical's stock has a predicted downside of -1.42% based on their 12-month stock forecasts.
: Over the previous 90 days, Intuitive Surgical's stock had 1 upgrade by analysts.
: Intuitive Surgical has been rated by research analysts at BTIG Research, Citigroup, Evercore ISI, JPMorgan Chase & Co., Leerink Partners, Mizuho, Oppenheimer, Piper Sandler, Raymond James, Redburn Atlantic, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, The Goldman Sachs Group, Truist Financial, and Wells Fargo & Company in the past 90 days.
: Analysts like Intuitive Surgical less than other "medical" companies. The consensus rating score for Intuitive Surgical is 2.68 while the average consensus rating score for "medical" companies is 2.79. Learn more on how ISRG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

[Urgent] Starlink Set For The Largest IPO In History? (Ad)

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Click here now for the urgent details on this hidden play.

This page (NASDAQ:ISRG) was last updated on 10/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

Intuitive Surgical (ISRG) Stock Forecast & Price Target